Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-23-002507

Director bought 2,500 shares at $24.96 ($62,396)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sigal Charles Elliott Director 2023-01-05 Purchase +2,500 $24.96 $62,396 7,500 I: show line 1 in the form
Open-market purchases · 2,500 sh · avg $24.96 · $62,396
Loading xslF345X03/doc4.xml…